Elsa Curtit

1.3k citations
59 papers · 956 · 1 hit paper · h-index 14

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 10%
    • PARP inhibition in cancer therapy
    • HER2/EGFR in Cancer Research

Papers in

    • Cancer survivorship and care 8
    • HER2/EGFR in Cancer Research 6
    • Breast Cancer Treatment Studies 10

Elsa Curtit

57 papers receiving 937 citations

Elsa Curtit's Hit Papers

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer 2022 · 329 citations
3290+1+2Years since publication100200300

Peers

Elsa Curtit
Comparison fields: 5 of 72
  • Cancer Research 262
  • Oncology 220
  • Hepatology 44
  • Genetics 126
  • Genetics 37
Replace Takao Yokoe with:
Takao Yokoe Japan
R. Morant Switzerland
R.E. Mansel United Kingdom
Sarita Dubey United States
Maria A. Picchi United States
Bastian Czogalla Germany
Samar J. Alhomoud Saudi Arabia
Kaoru Niimi Japan
Simone Scagnoli Italy
Elsa Curtit relative to Takao Yokoe Japan Takao Yokoe's profile →
Citations per field
00.5×5×10×13.7×
Takao Yokoe · 1×
Citations per year

Countries citing papers authored by Elsa Curtit

Since Specialization
Citations

This map shows the geographic impact of Elsa Curtit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsa Curtit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsa Curtit more than expected).

Fields of papers citing papers by Elsa Curtit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsa Curtit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsa Curtit. The network helps show where Elsa Curtit may publish in the future.

Co-authors

The 25 scholars most cited alongside Elsa Curtit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elsa Curtit Line = papers co-authored together Elsa Curtit links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Hit paper breakdown →
2022329
2 201380
3 201957
4 201144
5 201641
6 201633
7 201620
8 202220
9 201319
10 201218
11 201918
12 201916
13 201215
14 201915
15 202114
16 201613
17 201112
18 201111
19 202111
20 201110

About Elsa Curtit

Elsa Curtit is a scholar working on Oncology, Cancer Research, Genetics, Pulmonary and Respiratory Medicine and Genetics, having authored 59 papers that have together received 956 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (10 papers), Cancer survivorship and care (8 papers), HER2/EGFR in Cancer Research (6 papers), BRCA gene mutations in cancer (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Glioma Diagnosis and Treatment (4 papers), Sleep and related disorders (3 papers) and Genetic Associations and Epidemiology (3 papers). The work is most often cited by research in Cancer Research (262 citations), Oncology (220 citations), Hepatology (44 citations), Genetics (126 citations) and Genetics (37 citations). Elsa Curtit has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Xavier B. Pivot, Virginie Nerich, L. Chaigneau, Antoine Thiery-Vuillemin, Fernando Bazán, Philippe Montcuquet, Laura Mansi, Thierry Nguyen, Cristian Villanueva and Samuel Limat. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, BMC Cancer, Frontiers in Oncology and Breast Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact